High Versus Low Dose Serratus Anterior Plane Block After Minimally Invasive Valve Surgery.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJessa Hospital
About this trial
This study aims to compare the efficacy and quality of pain relief provided by the high-dose serratus anterior plane (SAP) block with the standard SAP block in preventing and treating acute postoperative pain after total endoscopic aortic or mitral valve surgery.
Eligibility criteria
Qualifiers
Scheduled for elective aortic valve surgery or elective mitral valve surgery via right anterolateral thoracotomy
Adult patients (minimally 18 years old)
Bodyweight > 50kg
EuroScore ii < 3%
Disqualifiers
Refusal to participate
Inability to communicate due to language or neurologic barriers
Inability to control and self-administer opioids with PCIA or to comprehend the NRS pain score due to confusion or learning difficulties
Chronic use of opioids
Trial design
Treatments tested in this trial
- High dose serratus anterior plane block (2.4 mg/kg patient ideal body weight)
- Low dose serratus anterior plane block (1.2mg/kg patient ideal body weight)
- PCIA with morphine
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov